We assigned the locus for a previously reported new type of autosomal dominant posterior polar cataract (CPP3) to 20p12-q12 by a genome-wide two-point linkage analysis with microsatellite markers. CPP3 is characterized by progressive, disc-shaped, posterior subcapsular opacity. The disease was seen in 10 members of a Japanese family and transmitted in an autosomal dominant fashion through four generations. We obtained a maximum lod score (Z max ) of 3.61 with a recombination fraction (θ) of 0.00 for markers D20S917, D20S885 and D20S874. Haplotype analysis gave the disease gene localization at a 15.7-cM interval between D20S851 and D20S96 loci on chromosome 20p12-q12. Since the BFSP1 that encodes the lens-specific beaded filament structural protein 1 (filensin) has been mapped around the CPP3 region, we performed sequence analysis on its entire coding region. However, no base substitution or deletion was detected in the CPP3 patients. The mapping of the CPP3 locus to 20p12-q12 not only expands our understanding of the genetic heterogeneity in autosomal dominant posterior polar cataracts but also is a clue for the positional cloning of the disease gene.
Introduction
Congenital cataract is one of the causes of visual impairment during infancy, and the prevalence is estimated to be 1.2-6.0 in 10 000 infants. 1 Approximately a quarter of the diseases is hereditary. 2 Among the various forms of congenital cataracts (zonular, polar, total, and membranous), posterior polar cataract (CPP) (MIM 116600) is the genetic term given to subcapsular opacities in the posterior polar regions of the lens. Posterior subcapsular opacities of the lens may occur not only in congenital cataracts but also in senile, diabetic, and steroidal-treated patients, and sometimes in those with neurofibromatosis type II or a type of retinitis pigmentosa.
Posterior lens opacities impair visual acuity because of their central or axial position; however, little is known about the underlying pathogenesis. Previous clinical and genetic studies on autosomal dominant congenital cataracts have identified at least 10 different loci, although allelic heterogeneity may exist in some of them. An autosomal dominant posterior polar cataract, defined as CPP1 (or CTPP1), has been tentatively assigned to 16q, 3 and another form, CPP2 (or CTPP2), is linked to 1p36. 
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We previously identified a new form of CPP, defined as CPP3 (or CTPP3), in a Japanese family in which 10 members in four generations were affected, and a genetic study excluded all known autosomal dominant congenital cataract loci. 21 Here we report the results of a genome-wide two-point linkage analysis of this CPP3 family.
Materials and methods

Family study
The proband is a 45-year-old Japanese man (III-6, Figure 1 ) with bilateral congenital posterior polar cataract. He belongs to a family in which a total of 10 members suffer (or suffered) from the cataract. The family descended from a group of people who immigrated from another region of Japan to Moriyama district in Nagasaki prefecture after a big religious war (the Shimabara war) about 400 years ago. Clinical data of the family have been described in detail elsewhere, and the cataract seen in 10 of them is referred to as CPP3. 21 In brief, representative manifestations of the disease include bilateral, disc-shaped, posterior polar cataracts, which progress gradually with diffuse cortical opacities, although variable expressivity is present within the family. The time of surgery also varied significantly. After informed consent was obtained, blood samples were prepared from seven affected members and nine unaffected members and/or their spouses. Their lymphocytes were immortalized as Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines. High-molecular weight genomic DNA was extracted directly from the blood samples or from their lymphoblastoid cell lines (Figure 1 ).
Genotyping and linkage analysis
A genome-wide screening was performed on the CPP3 family members using microsatellite polymorphic markers chosen to be spaced at 5-10 cM. Sets of polymerase chain reaction (PCR) primers for 450 Généthon microsatellite repeat markers 22 were synthesized. In each set, a forward primer was labeled with fluorescence dye, Cy5 (Amersham Pharmacia Biotech, Uppsala, Sweden), and its reverse primer was unlabeled. Genotypes of the family members for each marker locus were determined according to the DNA sequencerassisted method. 23 The resulting data were analyzed with a software (Fragment Manager™ version 1.2, Amersham Pharmacia Biotech) to determine genotypes. Two-point lod scores were calculated by MLINK of the FASTLINK software version 4.0P 24 under the following assumptions: a gene frequency of 0.0001, full penetrance, and equal allele frequencies at all the loci examined. Recombination distances between the marker loci were based on the Généthon linkage map.
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Sequence analysis of BFSP1 coding region The human beaded filament structural protein 1 gene (BFSP1, GenBank accession number: AF039655) that encodes filensin has been mapped to chromosome 20p11.23-p12.1. 25 In order to confirm the gene assignment, the Stanford G3 radiation hybrid panel (Research Genetics, Huntsville, AL, USA) was screened with a primer set designed from the 3'-UTR sequence of BFSP1. Results from the PCR were submitted to the Stanford Human Genome Center. Since the gene structure for BFSP1, its eight coding exons, 26 3'-ends intronic sequences of exon 3, and the intron-exon boundary sequences of exon 4-8 (GenBank accession Nos. Y16718, Y16719, Y16720, Y16721, Y16722, and Y16723, respectively) have been described, we determined intronic sequences flanking exon 1, exon 2 and exon 3 of the gene. A P1-derived artificial chromosome (PAC) library 27 was screened with the same primers for the radiation hybrid mapping, and an isolated PAC clone was used as a sequencing template. In order to analyze the entire BFSP1 exon sequence and splice signals in the CPP3 patients, PCR products from two patients (III-2 and III-6) were directly sequenced for the open reading frame (ORF) region, with primers designed from the exon-flanking intronic sequences ( Table 1 ). The sequences in the patients were compared to those of normal control individuals as well as to published gene sequences.
Results
The genome-wide two-point linkage analysis gave a high lod score (Z max = 3.61, θ = 0.00) at D20S917, D20S885 and D20S874 marker regions on chromosome 20. For further fine mapping of the disease locus, another series of 30 polymorphic markers 22 derived from the regions was tested. An overview of two-point lod scores between the CPP3 locus and relevant 12 markers is shown in Table 2 .
Haplotype analysis of the affected family members revealed three recombination events that narrowed the disease gene localization (Figure 1) . One recombination occurred in individual III-6 between D20S851 and D20S917, and the recombinant chromosome was inherited by his two children; another recombination was observed in III-2 between D20S96 and D20S888, and the other recombination was found in his daughter (IV-2) between D20S874 and D20S96. Thus, a haplotype segment common to all the affected members ranges from D20S917 to D20S899, and a critical region for CPP3 lies between the D20S851 and D20S96 loci.
The radiation hybrid panel mapping revealed that BFSP1 is linked to an STS, D20S114, with a lod score of > 6.0. This indicated that BFSP1 is localized 10.89 cR from the STS and between D20S1015 and D20S182 GDB loci. The resulting intronic sequences flanking exon 1, exon 2 and exon 3 of BFSP1 have been deposited at GenBank (GenBank accession numbers, AF191045, AF191046, and AF191047). Sequence analysis on the BFSP1 ORF region revealed no evidence of mutation in the two CPP3 patients, but two silent polymorphisms were detected in exons 7 and 8 in normal control individuals (data not shown).
Discussion
We assigned an autosomal dominant posterior polar cataract (CPP3) to chromosome 20p12-q12, to which no cataract loci 
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y had yet been assigned. Although, the size of the critical region is 33.9 cM, based on the sex average map, 22 most of the meioses scored in this family occurred in males, it is more appropriate to estimate the size from the male linkage map than from the sex average map. 22 In this case, the critical region decreases to 15.7 cM. CPP3 is a new clinical form of autosomal dominant cataract characterized by bilateral, discshaped posterior polar opacities which grow larger and denser, progress with cortical opacities, and finally lead to total cataract. 21 Two autosomal dominant forms of CPP, CPP1
and CPP2, have been identified. Several genes and ESTs that may be related to eye diseases have been assigned to the region to which we assigned the CPP3 locus. They include PLCB4 ( -4 phospholipase C gene, MIM 600810), BFSP1 (filensin gene, MIM 603307), PLCG1 (γ-1 phospholipase C gene, MIM 172420), MYBL2 (locus for V-myb avian myeloblastosis viral oncogene homolog-like 2, MIM 601415), SDC4 (gene for amphiglycan ryudocan, MIM 600017), and KRLM (Kreisler mouse maf-related leucine zipper homolog, GenBank accession number, NM 005461 26 This allowed us to analyze patients in the CPP3 family as to whether they have a BFSP1 mutation. However, there was no evidence of base substitutions or deletions in the protein coding region of the gene in our patients. Thus, it is unlikely that BFSP1 mutations cause CPP3, though it remains to be determined whether there is a mutation in the non-coding regions of BFSP1, including the promoter region and introns. Understanding of the CPP3 gene will give insight into specific features of lens function and dysfunction. 
